The PIN4 gene was identified through a search of an expressed sequence tag (EST) database using human PIN1 and Escherichia coli parvulin sequences as probes. This led to the isolation of a cDNA encoding PIN4 from a lung cDNA library . The gene encoding PIN4 is located on the X chromosome and is expressed in various tissues, indicating its fundamental role in cellular processes .
PIN4 has a unique structure that includes a peptidyl-prolyl isomerase domain, which is responsible for its enzymatic activity. This domain contains a nucleophilic cysteine residue (Cys113) that is crucial for its function . The enzyme catalyzes the cis/trans isomerization of proline residues in polypeptides, a process that is essential for proper protein folding and function .
PIN4 plays a significant role in several cellular processes, including the cell cycle, chromatin remodeling, and ribosome biogenesis . It is involved in the regulation of various signaling pathways by inducing conformational changes in key signaling molecules following proline-directed phosphorylation . This regulation is critical for maintaining cellular homeostasis and function.
The deregulation of PIN4 has been implicated in various diseases, particularly cancer. Overexpression of PIN4 has been observed in several types of cancer, including breast, cervical, ovarian, and endometrial cancers . This overexpression promotes cell proliferation and transformation, contributing to tumorigenesis . Targeting PIN4 with specific inhibitors has shown promise in reducing tumor progression and increasing survival in preclinical models .
Recent research has focused on developing specific inhibitors for PIN4 to explore its therapeutic potential. One such inhibitor, Sulfopin, has demonstrated high affinity binding to PIN4 and inhibition of its catalytic activity . In preclinical studies, Sulfopin treatment led to tumor regression and increased survival in mouse models of cancer . These findings highlight the potential of PIN4 as a therapeutic target for cancer treatment.